TG Therapeutics is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Company (Alive / Active)
Phone: 212-554-4484
2 Gansevoort Street
9th Floor
New York, 10014
New York, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Combination of anti-cd20 antibody and pi3 kinase selective inhibitor | Jun 28, 2017 | Aug 04, 2020 | Patent |
Converting programs to visual representation with intercepting screen draws | Jan 20, 2015 | Apr 07, 2020 | Patent |
Localization of embedded databases | Aug 10, 2017 | Jun 25, 2019 | Patent |
Multimedia terminal | May 02, 2016 | Nov 14, 2017 | Patent |
Display screen with graphical user interface for a portable terminal | Feb 22, 2016 | Oct 10, 2017 | Patent |